October 2018 | Volume 1
Arthroscopy/Soft Tissue Repair Companies Worth Watching
Active Implants, BioRez, CartiHeal, Cartiva, Ceterix, CoNextions, Hyalex, OrthoSpace, Orthonika, Trice Medical and Ziptek are innovating--
Surgeon Entrepreneurs Focus on Infection Prevention, Virtual Reality Training
Drs. Javad Parvizi and Justin Barad are thinking differently about product development--while maintaining a focus on improved patient outcomes.
NASS Recap: Conversations Center On Additive, Robotics, Materials
OEMs, suppliers and surgeons confirm that the spine industry remains fixated on procedure enhancement through surgical assistance technologies and device design via coatings, materials and manufacturing.
Complimentary 1-year Print Subscription
Enter code "ENEWS" at checkout.
eifeler Coatings Technology
Fountainhead Investment Partners
SRS Investment Management
Flex-Cell now ISO 13485:2016/9001:2015 Certified
Healthpoint Capital Closes $100MM for New Fund
Materialise Launches Additive Simulation Software
Corin to Acquire Global Orthopaedic Technology
Corin targeted GOT as part of its plan for global expansion in the joint reconstruction market.
GOT has an Australian footprint and an export business in the USA.
Medacta, our #13 Device Company by Revenue, Appoints New CEO
After twenty years at the helm, founder Dr. Alberto Siccardi will transition CEO duties to his son,
Francesco Siccardi, currently Executive Vice President of Medacta International
How to Respond to FDA Form 483 Observations, Even Those You Dispute
You must demonstrate to
FDA that you are in control of the situation and are attempting to comply voluntarily by doing everything possible to ensure Agency specifications are met.
Orthobiologic Clinical Studies Update
Two completed study announcements include Bone Therapeutics' ALLOB® allogenic bone cell therapy to treat fractures and Histogenics' NeoCart® to treat knee cartilage defects.
From the archives:
Five Steps to Regulatory Strategy Development
solid strategy and subsequent execution can maximize the opportunity
to achieve a specific regulatory goal, such as to obtain approval or clearance of a new orthopaedic product.
Copyright © 2018. All Rights Reserved.